Idebenone 58186-27-9 Smart Drugs Memory Enhancing 99% Purity Strong Effect

Basic Information
Place of Origin: CHINA
Brand Name: TINGYI
Certification: GMP , ISO 9001:2008
Model Number: 58186-27-9
Minimum Order Quantity: 10g
Price: Contact Me
Packaging Details: Disguised Package
Delivery Time: 2 Working Days
Payment Terms: Bank Transfer - Bitcoin - Western Union - MoneyGram
Supply Ability: 100 KG/Month
Product Name: Idebenone CAS: 58186-27-9
Appearance: Yellow-orange Crystalline Powder Usage: Nootropics Drug
Shipping Method: EMS, HKEMS, FEDEX, DHL, UPS, Aramex, ETC Synonym: Avan
High Light:

pharmaceutical anabolic steroids


pharmaceutical fine chemicals

Basic info

Product name Idebenone
Assay 99%
CAS No 58186-27-9
M.F. C19H30O5
M.W. 338.44
Purity 99.5%
Melting Point 52-55º C
Boiling Point 497.3º C at 760 mmHg
Flash Point 170.1º C
Density 1.08 g/cm3
Storage Store in room temp
Appearance Yellow-orange crystalline powder
Quality Standard Enterprise Standard
Usage Treatment of depression.
Standard USP/BP
Price Negotiated
Minimum order quantity Negotiated
Package Exquisite and can according to customers' requirement
Shipping leading time Within 8 hours after receiving the payment
Payment options Western Union, MoneyGram, bank transfer , Bitcoin, Litecoin
Shipping Express delivery with DHL, EMS, Fedex, HKEMS, TNT, UPS (within 5-7days after payment)




Items of analysis Specification Results
Appearance yellow or orange yellow crystalline powder yellow or orange yellow crystalline powder
Identification Chemical or IR Method Positive
Loss on Drying ≤0.5% 0.19%
Assay (HPLC) ≥99.0% 99.34%
Melting Point 52~53ºC 52~53ºC
Residue on Ignition ≤0.1% 0.04%
Related substance ≤0.5% 0.01%
Heavy Metals ≤10ppm <10ppm
Iron ≤50ppm <50ppm
Sulfate ≤500ppm <500ppm
Arsenic ≤2ppm <2ppm
Lead ≤3ppm <3ppm
Mercury ≤0.1ppm <0.1ppm
Cadmium ≤1ppm <1ppm
Conclusion Qualified


What are nootropics?

       Nootropics also referred to as smart drugs, memory enhancers, neuro enhancers, cognitive enhancers, and intelligence enhancers, aredrugs, supplements, nutraceuticals, and functional foods that purportedly improve mental functions such as cognition, memory, intelligence,motivation, attention, and concentration. Nootropics are thought to work by altering the availability of the brain's supply of neurochemicals (neurotransmitters, enzymes, andhormones), by improving the brain's oxygen supply, or by stimulating nerve growth.





       Chemically, idebenone is an organic compound of the quinone family. It is also promoted commercially as a synthetic analog of coenzyme Q10 (CoQ10).


       Idebenone (pronounced eye-deb-eh-known, trade names Catena, Raxone, Sovrima, among others) is a drug that was initially developed by Takeda Pharmaceutical Company for the treatment of Alzheimer's disease and other cognitive defects. This has been met with limited success. The Swiss company Santhera Pharmaceuticals has started to investigate it for the treatment of neuromuscular diseases. In 2010, early clinical trials for the treatment of Friedreich's ataxia and Duchenne muscular dystrophy have been completed. As of December 2013 the drug is not approved for these indications in North America or Europe, but it is approved for the treatment of Leber's hereditary optic neuropathy (LHON) in Europe.





       Idebenone is used for Alzheimer's disease, liver disease, and heart disease; as well as a number of inherited disorders including Leber's disease (an eye condition), mitochondrial encephalomyopathies (nerve and muscle disorders), and Friedreich's ataxia (a nervous system disorder that worsens over time, producing gait and speech problems, and eventually leading toward heart disease and diabetes).

       Idebenone is an organic compound belonging to the quinone family, being similar to coenzyme Q-10. It is a kind of drug developed by Takeda Pharmaceutical Company for the treatment of Alzheimer’s disease and some other cognitive defects. However, these have been not very much progress associated with this indication. It is now also used for the treatment of Friedreich’s ataxia with a positive effect on cardiac hypertrophy and neurological function.


        However, this indication is only approved in Canada, not in Europe and US. It is now under investigation on its efficacy for the treatment of Duchenne muscular dystrophy, Leber’s hereditary optic neuropathy, mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) as well as primary progressive multiple sclerosis. The efficacy of this drug still demands more evidences.





        1.Idebenone increases nerve growth factor (NGF) in the brain.
        2.Idebenone is a powerful antioxidant and positively affects brain chemistry.
        3.Idebenone has been shown to promote information transfer across the corpus callosum, the membrane separating the right and left brain hemispheres.
        4. Idebenone has been used to treat Alzheimer's and to lessen damage from strokes.
        5. Idebenone can increase production of the brain neurotransmitters serotonin, dopamine, adrenalin, and noradrenanlin.

Idebenone 58186-27-9 Smart Drugs Memory Enhancing 99% Purity Strong Effect 0


Contact Details
Sales Manager

WhatsApp : +8613657291547